SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-667395
Filing Date
2016-08-02
Accepted
2016-08-02 06:31:47
Documents
63
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d202056d10q.htm 10-Q 511334
2 EX-31.1 d202056dex311.htm EX-31.1 6406
3 EX-31.2 d202056dex312.htm EX-31.2 6406
4 EX-32.1 d202056dex321.htm EX-32.1 3312
5 EX-32.2 d202056dex322.htm EX-32.2 3321
  Complete submission text file 0001193125-16-667395.txt   2556508

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT idra-20160630.xml EX-101.INS 405442
7 XBRL TAXONOMY EXTENSION SCHEMA idra-20160630.xsd EX-101.SCH 36561
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE idra-20160630_cal.xml EX-101.CAL 54708
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE idra-20160630_def.xml EX-101.DEF 89493
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE idra-20160630_lab.xml EX-101.LAB 240169
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idra-20160630_pre.xml EX-101.PRE 167718
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 161798879
SIC: 2836 Biological Products, (No Diagnostic Substances)